Adjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer

Case Medical Research ◽

10.31525/ct1-nct04254263 ◽

2020 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Her 2 ◽

Positive Breast Cancer

Download Full-text

Neoadjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer

Case Medical Research ◽

10.31525/ct1-nct04126525 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Her 2 ◽

Positive Breast Cancer

Download Full-text

Oral Contraceptive Use and HER-2/neu-Positive Breast Cancer Among White and Black Women.

10.21236/ada306141 ◽

1996 ◽

Author(s):

Marilie Gammon

Keyword(s):

Breast Cancer ◽

Oral Contraceptive ◽

Black Women ◽

Contraceptive Use ◽

Oral Contraceptive Use ◽

Her 2 ◽

Positive Breast Cancer

Download Full-text

Phase II Study of HER-2/neu Intracellular Domain Peptide-Based Vaccine Administered to Stage IV HER2 Positive Breast Cancer Patients Receiving Trastuzumab

10.21236/ada471552 ◽

2007 ◽

Author(s):

Mary L. Disis

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Stage Iv ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Her 2 ◽

Domain Peptide ◽

Positive Breast Cancer

Download Full-text

Phase II Study of a HER-2/neu Intracellular Domain Peptide-Based Vaccine Administered to Stage IV HER2 Positive Breast Cancer Patients Receiving Trastuzumab

10.21236/ada533841 ◽

2010 ◽

Author(s):

Mary L. Disis

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Stage Iv ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Her 2 ◽

Domain Peptide ◽

Positive Breast Cancer

Download Full-text

Phase 2 Study of a HER-2/neu Intracellular Domain Peptide-Based Vaccine Administered to Stage IV HER2 Positive Breast Cancer Patients Receiving Trastuzumab

10.21236/ada538840 ◽

2010 ◽

Author(s):

Mary L. Disis

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Stage Iv ◽

Phase 2 ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Phase 2 Study ◽

Her 2 ◽

Domain Peptide ◽

Positive Breast Cancer

Download Full-text

The efficacy and safety of Tyrosine kinase inhibitors in HER-2 positive breast cancer with brain metastases: a systematic review and meta analysis

10.1016/s0960-9776(21)00145-4 ◽

2021 ◽

Vol 56 ◽

pp. S41

Author(s):

Y. Yu ◽

J. Zhang ◽

K. Huang ◽

Y. Lin ◽

C. Song

Keyword(s):

Breast Cancer ◽

Systematic Review ◽

Brain Metastases ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Efficacy And Safety ◽

Her 2 ◽

Positive Breast Cancer

Download Full-text

Pituitary Metastasis in HER-2 positive breast cancer with initial presentation of hypernatremia: Two case reports

Current Problems in Cancer: Case Reports ◽

10.1016/j.cpccr.2021.100107 ◽

2021 ◽

pp. 100107

Author(s):

Ming-Jung Meng ◽

Yung-Chang Lin

Keyword(s):

Breast Cancer ◽

Case Reports ◽

Initial Presentation ◽

Her 2 ◽

Positive Breast Cancer ◽

Pituitary Metastasis

Download Full-text

104P Pathologic tumor response & long term outcome with neoadjuvant trastuzumab in Her-2 positive breast cancer

Annals of Oncology ◽

10.1016/s0923-7534(21)00263-5 ◽

2016 ◽

Vol 27 ◽

pp. ix31

Author(s):

S. Zeeshan ◽

S.M. Khan ◽

N. Khan

Keyword(s):

Breast Cancer ◽

Tumor Response ◽

Term Outcome ◽

Long Term Outcome ◽

Her 2 ◽

Positive Breast Cancer

Download Full-text

Neratinib in HER-2-positive breast cancer: results to date and clinical usefulness

Therapeutic Advances in Medical Oncology ◽

10.1177/1758834016656494 ◽

2016 ◽

Vol 8 (5) ◽

pp. 339-350 ◽

Author(s):

Arlene Chan

Keyword(s):

Breast Cancer ◽

Clinical Usefulness ◽

Her 2 ◽

Positive Breast Cancer

Download Full-text

Computational Model to Explore the Endocrine Response to Trastuzumab Action in HER-2/neu Positive Breast Cancer

Saudi Journal of Biological Sciences ◽

10.1016/j.sjbs.2021.08.061 ◽

2021 ◽

Author(s):

Fuzhang Wang ◽

Qurat Ul Ain Azim ◽

João Manuel R.S. Tavares ◽

Ayesha Sohail ◽

Alessandro Nutini ◽

...

Keyword(s):

Breast Cancer ◽

Computational Model ◽

Endocrine Response ◽

Her 2 ◽

Positive Breast Cancer

Download Full-text